Center for Vaccine Development and Global Healthhttp://hdl.handle.net/10713/68432024-03-28T21:39:46Z2024-03-28T21:39:46ZUMB's Neuzil Named Marylander Of The YearPayne, Januaryhttp://hdl.handle.net/10713/142862022-04-21T17:12:01Z2021-01-02T00:00:00ZUMB's Neuzil Named Marylander Of The Year
Payne, January
In this article in the UMB News, January Payne reports that Kathleen Neuzil, MD, MPH, FIDSA, the Myron M. Levine, MD, DTPH, Professor in Vaccinology and director of the University of Maryland School of Medicine’s (UMSOM) Center for Vaccine Development and Global Health (CVD), has been named this year’s “Marylander of the Year” by The Baltimore Sun. In a historic and challenging year dominated by COVID-19, The Sun editors also named front-line health care and service workers as co-recipients along with Neuzil, for their essential roles in the battle against the novel coronavirus.
2021-01-02T00:00:00ZNIH Grant Funds Search for Next-Generation Flu VaccineMorrison, Joannehttp://hdl.handle.net/10713/110272020-04-15T17:21:25Z2019-09-20T00:00:00ZNIH Grant Funds Search for Next-Generation Flu Vaccine
Morrison, Joanne
News release describing the announcement of the award of a 200 million dollar contract from the National Institute of Allergy and Infectious Diseases to UMB’s Center for Vaccine Development and Global Health. The funds will support research efforts into developing a universal influenza vaccine.
2019-09-20T00:00:00ZAnalyzing the Impact of a Rotavirus Vaccine in Africahttp://hdl.handle.net/10713/105272020-04-14T18:37:31Z2017-11-27T00:00:00ZAnalyzing the Impact of a Rotavirus Vaccine in Africa
News release discussing the UMB Center for Vaccine Development's, Vaccine Impact on Diarrhea in Africa (VIDA) project, led by Karen Kotloff, MD. The study began 14 to 21 months subsequent to the introduction of rotavirus vaccines in The Gambia, Mali, and Kenya. Vaccination impact will be assessed by comparing before and after data associated with the etiology and incidence of moderate-to-severe diarrhea in children 0-59 months.
2017-11-27T00:00:00ZUMSOM Researchers Unveil Progress and Challenges in Introducing Typhoid Conjugate Vaccine in Sub-Saharan Africa and AsiaMorrison, Joannehttp://hdl.handle.net/10713/98342019-08-30T08:48:28Z2019-03-08T00:00:00ZUMSOM Researchers Unveil Progress and Challenges in Introducing Typhoid Conjugate Vaccine in Sub-Saharan Africa and Asia
Morrison, Joanne
Each year there are nearly 11 million cases of typhoid, a disease that is
spread through contaminated food, drink and water. Researchers at the
University of Maryland School of Medicine are leading an international
consortium that is studying the impact of a typhoid conjugate vaccine (TCV) in
an effort to accelerate introduction of the vaccine in countries in sub-Saharan
Africa and Asia where there is a high burden of typhoid.
2019-03-08T00:00:00Z